Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | DRD4 | P21917 | 3/20 | 0.51 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7810022 | 0.95 | NPC1 (0.54) | S1PR1NPC1RAB9ADRD4PARP14 | |
| SCHEMBL7811596 | 0.90 | NPC1 (0.51) | NPC1RAB9ADRD4PARP14PARP10 | |
| SCHEMBL7817826 | 0.88 | NPC1 (0.56) | NPC1RAB9ADRD4PARP14PARP10 | |
| SCHEMBL9259543 | 0.86 | DRD4 (0.61) | S1PR1NPC1RAB9ADRD4PARP14 | |
| SCHEMBL7804397 | 0.84 | NPC1 (0.52) | NPC1RAB9ADRD4PARP10HRH3 | |
| SCHEMBL7811616 | 0.84 | NPC1 (0.52) | NPC1RAB9ADRD4PARP14PARP10 | |
| SCHEMBL9010961 | 0.84 | DRD4 (0.60) | S1PR1NPC1RAB9ADRD4PARP14 | |
| SCHEMBL7804406 | 0.83 | S1PR1 (0.57) | S1PR1NPC1PARP14PARP10HSD11B1 | |
| SCHEMBL7814084 | 0.83 | HRH1 (0.56) | S1PR1HRH3HRH1LMNATSHR | |
| SCHEMBL7804503 | 0.83 | LMNA (0.68) | NPC1RAB9APOLBHPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0607536-B1 | Arylamide derivatives | SS PHARMACEUTICAL CO (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-5532371-A | SIDE EFFECT REDUCTION | SS PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5411972-A | Arylamide derivatives for treating hyperlipemia | SS PHARMACEUTICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0607536-A1 | Arylamide derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |